Literature DB >> 12692219

Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5' splice sites that bind a U1 snRNP-like complex.

Sarah A Cumming1, Maria G McPhillips, Thanaporn Veerapraditsin, Steven G Milligan, Sheila V Graham.   

Abstract

The human papillomavirus (HPV) life cycle is tightly linked to differentiation of the squamous epithelia that it infects. Capsid proteins, and hence mature virions, are produced in the outermost layer of differentiated cells. As late gene transcripts are produced in the lower layers, posttranscriptional mechanisms likely prevent capsid protein production in less differentiated cells. For HPV type 16 (HPV-16), a 79-nucleotide (nt) negative regulatory element (NRE) inhibits gene expression in basal epithelial cells. To identify key NRE sequences, we carried out transient transfection in basal epithelial cells with reporter constructs containing the HPV-16 late 3' untranslated region with deletions and mutations of the NRE. Reporter gene expression was increased over 40-fold by deletion of the entire element, 10-fold by deletion of the 5' portion of the NRE that contains four weak consensus 5' splice sites, and only 3-fold by deletion of the 3' GU-rich region. Both portions of the element appear to be necessary for full repression. Inactivating mutations in the 5' splice sites in the 5' NRE partially alleviated repression in the context of the 79-nt NRE but caused full derepression when assayed in a construct with the 3' NRE deleted. All four contribute to the inhibitory effect, though the second splice site is most inhibitory. Sm proteins, U1A and U1 snRNA, but not U1 70K, could be affinity purified with the wild-type NRE but not with the NRE containing mutations in the 5' splice sites, indicating that a U1 snRNP-like complex forms upon the element.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692219      PMCID: PMC153945          DOI: 10.1128/jvi.77.9.5167-5177.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Sm protein-Sm site RNA interactions within the inner ring of the spliceosomal snRNP core structure.

Authors:  H Urlaub; V A Raker; S Kostka; R Lührmann
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

2.  U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase.

Authors:  S I Gunderson; M Polycarpou-Schwarz; I W Mattaj
Journal:  Mol Cell       Date:  1998-01       Impact factor: 17.970

3.  The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels.

Authors:  M D Koffa; S V Graham; Y Takagaki; J L Manley; J B Clements
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

4.  Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression.

Authors:  S S Terhune; W G Hubert; J T Thomas; L A Laimins
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing.

Authors:  M Caputi; A Mayeda; A R Krainer; A M Zahler
Journal:  EMBO J       Date:  1999-07-15       Impact factor: 11.598

6.  The carboxyl terminus of vertebrate poly(A) polymerase interacts with U2AF 65 to couple 3'-end processing and splicing.

Authors:  S Vagner; C Vagner; I W Mattaj
Journal:  Genes Dev       Date:  2000-02-15       Impact factor: 11.361

7.  A complex containing CstF-64 and the SL2 snRNP connects mRNA 3' end formation and trans-splicing in C. elegans operons.

Authors:  D Evans; I Perez; M MacMorris; D Leake; C J Wilusz; T Blumenthal
Journal:  Genes Dev       Date:  2001-10-01       Impact factor: 11.361

8.  The human papillomavirus type 31 late 3' untranslated region contains a complex bipartite negative regulatory element.

Authors:  Sarah A Cumming; Claire E Repellin; Maria McPhillips; Jonathan C Radford; J Barklie Clements; Sheila V Graham
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

9.  Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2.

Authors:  B Collier; L Goobar-Larsson; M Sokolowski; S Schwartz
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

10.  A modular system for the assay of transcription regulatory signals: the sequence TAATGARAT is required for herpes simplex virus immediate early gene activation.

Authors:  D F Gaffney; J McLauchlan; J L Whitton; J B Clements
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

View more
  19 in total

Review 1.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

2.  A bipartite U1 site represses U1A expression by synergizing with PIE to inhibit nuclear polyadenylation.

Authors:  Fei Guan; Rose M Caratozzolo; Rafal Goraczniak; Eric S Ho; Samuel I Gunderson
Journal:  RNA       Date:  2007-10-17       Impact factor: 4.942

3.  A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein.

Authors:  Xiaomin Zhao; Daniel Oberg; Margaret Rush; Joanna Fay; Helen Lambkin; Stefan Schwartz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Construction of a full transcription map of human papillomavirus type 18 during productive viral infection.

Authors:  Xiaohong Wang; Craig Meyers; Hsu-Kun Wang; Louise T Chow; Zhi-Ming Zheng
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

Review 5.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

6.  Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.

Authors:  Xiaomin Zhao; Margaret Rush; Stefan Schwartz
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells.

Authors:  Maria G McPhillips; Thanaporn Veerapraditsin; Sarah A Cumming; Dimitra Karali; Steven G Milligan; Winifred Boner; Iain M Morgan; Sheila V Graham
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 8.  Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies.

Authors:  Sheila V Graham
Journal:  Future Microbiol       Date:  2010-10       Impact factor: 3.165

9.  Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.

Authors:  Sarah Mole; Steven G Milligan; Sheila V Graham
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

10.  The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells.

Authors:  S A Cumming; T Chuen-Im; J Zhang; S V Graham
Journal:  Virology       Date:  2008-11-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.